Review



4800 human genes  (Illumina Inc)


Bioz Verified Symbol Illumina Inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Illumina Inc 4800 human genes
    4800 Human Genes, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 96/100, based on 663 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+fc+sequence/TruSight+One+Sequencing+Panel/pmc07322863-25-4-11
    Average 96 stars, based on 663 article reviews
    4800 human genes - by Bioz Stars, 2026-11
    96/100 stars

    Images

    Related Articles

    Sequencing:

    Article Title: Detecting monogenic obesity: a systematic exome-wide workup of over 500 individuals
    Article Snippet: Sequencing was performed on Illumina NovaSeq 6000 (TWIST, TWIST 2.0), BGISEQ-500 (BGI), or an Illumina NextSeq- or HighSeq platform (Nextera, Agilent). .. The remaining 15.3% of patients ( n = 81) received genetic diagnostics based on the TruSight One Sequencing Panel (4,813 genes, Supplementary Table ), using the TruSight Rapid Capture Kit and Illumina NextSeq550. ..

    Article Title: Intrinsic errors in mitochondrial translation trigger a decline in cell fitness
    Article Snippet: DNA library preparation was performed using NEBNext Ultra DNA Library Prep kit following the manufacturer’s instructions (Illumina, San Diego, CA, USA). .. The libraries were pooled equimolar and loaded with a 30% spike-in of PhiX Sequencing Control V3 on a S4 flowcell on the Illumina NovaSeq 6000 instrument according to manufacturer’s instructions. ..

    Article Title: A novel splice site variant in TIMM8A induced abnormal mRNA splicing resulting in Mohr–Tranebjaerg syndrome
    Article Snippet: Background: Mohr-Tranebjaerg syndrome (MTS) is an X-linked recessive neurodegenerative disorder caused by pathogenic variants in TIMM8A.. Of the 39 previously reported disease-causing variants in the TIMM8A, five are splice site variants; however, none of these variants have been evaluated by transcript analysis.. Methods: We performed panel-based targeted exome analysis in a Japanese boy with sensorineural hearing loss and rapidly progressive dystonia.

    Article Title: Kif11-haploinsufficient oocytes reveal spatially differential requirements for chromosome biorientation.
    Article Snippet: .. Reagents and tools table Reagent/resource Reference or source Identifier or catalog number Experimental models C57BL/6NCrSlc (M. musculus) Japan SLC B6D2F1/Slc (M. musculus) Japan SLC (C57BL/6NCrSlc ♀ × DBA/2CrSlc ♂) F1 Tg(Spo11-cre)1Rsw (M. musculus) The Jackson Laboratory (Lyndaker et al, 2013) 032646 Tg(Gdf9-icre)5092Coo (M. musculus) The Jackson Laboratory (Lan et al, 2004) 011062 Tg(Zp3-cre)3Knw(M. musculus) The Jackson Laboratory (de Vries et al, 2000) 003651 Kif11 flox (M. musculus) This study Kif11flox/flox Zp3-Cre (M. musculus) This study Kif11flox/flox Gdf9-Cre (M. musculus) This study Recombinant DNA pGEMHE_EGFP-Map4 Schuh and Ellenberg 2007 pGEMHE_H2B-mCherry Kitajima et al, 2011 pGEMHE_mNeonGreenCep192 Kyogoku and Kitajima 2017 (originally Clift and Schuh 2015) pGEMHE_mCherry Asai et al, 2024 pGEMHE_Kif11-mCherry This study Reagent/resource Reference or source Identifier or catalog number pGEMHE_Kif11ΔmotormCherry This study pGEMHE_H2B-SNAP Takenouchi et al, 2024 Antibodies human anti-centromere protein antibody Antibodies Incorporated 15-234 rabbit anti-Kif11 Sigma HPA010568 rat monoclonal anti-alpha tubulin Bio-Rad MCA77G Alexa Fluor 488 goat antirabbit IgG (H+ L) Thermo Fisher A11034 Alexa Fluor 488 goat antirat IgG (H+ L) Thermo Fisher A11006 Alexa Fluor 555 goat antihuman IgG (H+ L) Thermo Fisher A21433 Oligonucleotides and other sequence-based reagents custom ssODN This study; Fasmac Figure EV1 crRNA Fasmac GE-001 tracrRNA Fasmac GE-002 Chemicals, enzymes and other reagents Equine chorionic gonadotropin ASKA Pharmaceutical G4877-2000IU CARD HyperOva KYUDO F-021 mMESSAGE mMACHINE T7 kit invitrogen AM1344 3-isobutyl-1-methylxanthine Sigma-Aldrich 15879 monastrol Sigma-Aldrich M815 EcoRV New England Biolabs R0195S SNAP-Cell 647-SiR New England Biolabs S9102S Hoechst 33342 Invitrogen H3570 SMART-Seq v4 Ultra Low Input RNA Kit for Sequencing Clontech 634891 Nextera XT DNA Library Preparation Kit Illumina FC-131-1096 8 EMBO reports © The Author(s) D ow nloaded from https://w w w .em bopress.org on Septem ber 7, 2025 from IP 2405:4803:dadf:58d0:bc82:365e:71c7:1d84. .. Reagent/resource Reference or source Identifier or catalog number Nextera XT Index Kit Illumina FC-131-1001 SPRISelect kit Beckman Coulter B23318 Software Fiji https://fiji.sc/ Imaris Oxford Instruments base R (v4.3.0) R Foundation for Statistical Computing fastp Chen et al, 2018 HiSat2 v2.2.1 Kim et al, 2019 SAMtools Danecek et al, 2021 featureCounts v2.0.3 Liao et al, 2014 DESeq2 Love et al, 2014 Other Illumina HiseqX Illumina LSM780, 880 confocal microscope Zeiss

    Article Title: Detecting monogenic obesity: a systematic exome-wide workup of over 500 individuals.
    Article Snippet: Sequencing was performed on Illumina NovaSeq 6000 (TWIST, TWIST 2.0), BGISEQ-500 (BGI), or an Illumina NextSeq- or HighSeq platform (Nextera, Agilent). .. The remaining 15.3% of patients (n= 81) received genetic diagnostics based on the TruSight One Sequencing Panel (4,813 genes, Supplementary Table 1), using the TruSight Rapid Capture Kit and Illumina NextSeq550. ..

    Article Title: Real-World Evidence on Outcomes and Safety of Ropeginterferon Alfa-2b in Patients With Myeloproliferative Neoplasms: A Retrospective Cohort Study.
    Article Snippet: This retrospective cohort study evaluated ropeginterferon alfa-2b in 64 patients with Philadelphia chromosome–negative myeloproliferative neoplasms.. Ropeginterferon demonstrated hematologic and molecular responses across subtypes, with significant reductions in JAK2 variant allele frequency.. However, efficacy was limited in myelofibrosis, particularly in patients harboring high-molecular-risk mutations.

    Article Title: Homozygous LMNA (p.Arg216His) variant in an Ecuadorian patient with atrial flutter and high-grade atrioventricular block: a case report
    Article Snippet: .. Sequencing libraries were prepared with the TruSight Cardio Sequencing Kit (Illumina) and sequenced on the MiSeq platform. .. Sequence reads were processed and aligned to the GRCh38/hg38 human reference genome using the DRAGEN Enrichment pipeline in BaseSpace Sequence Hub, and variants were annotated using the Ensembl Variant Effect Predictor.

    Article Title: Liver single-nucleus multiome profiling reveals cell-type mechanisms for cardiometabolic traits
    Article Snippet: We purified sequencing libraries using SPRIselect beads, visualized using the Bioanalyzer High Sensitivity DNA chip, and quantified via KAPA Library Quantification Kit for Illumina Platforms (Roche PN-KK4824). .. We separately pooled ATAC and RNA sequencing libraries, spiked with 1% PhiX sequencing control (Illumina), and sequenced on a NovaSeq 6000 S4 array at the UNC High Throughput Sequencing Facility in paired-end format to a total depth of ~8 billion read pairs passing quality filters. .. We used CellRanger-ARC Count v2 (10X Genomics) to align sequencing reads to the GRCh38–2020-A human reference genome, using the filtered GENCODE V32 33 GTF file for gene quantification.

    Control:

    Article Title: Intrinsic errors in mitochondrial translation trigger a decline in cell fitness
    Article Snippet: DNA library preparation was performed using NEBNext Ultra DNA Library Prep kit following the manufacturer’s instructions (Illumina, San Diego, CA, USA). .. The libraries were pooled equimolar and loaded with a 30% spike-in of PhiX Sequencing Control V3 on a S4 flowcell on the Illumina NovaSeq 6000 instrument according to manufacturer’s instructions. ..

    Article Title: Liver single-nucleus multiome profiling reveals cell-type mechanisms for cardiometabolic traits
    Article Snippet: We purified sequencing libraries using SPRIselect beads, visualized using the Bioanalyzer High Sensitivity DNA chip, and quantified via KAPA Library Quantification Kit for Illumina Platforms (Roche PN-KK4824). .. We separately pooled ATAC and RNA sequencing libraries, spiked with 1% PhiX sequencing control (Illumina), and sequenced on a NovaSeq 6000 S4 array at the UNC High Throughput Sequencing Facility in paired-end format to a total depth of ~8 billion read pairs passing quality filters. .. We used CellRanger-ARC Count v2 (10X Genomics) to align sequencing reads to the GRCh38–2020-A human reference genome, using the filtered GENCODE V32 33 GTF file for gene quantification.

    Recombinant:

    Article Title: Kif11-haploinsufficient oocytes reveal spatially differential requirements for chromosome biorientation.
    Article Snippet: .. Reagents and tools table Reagent/resource Reference or source Identifier or catalog number Experimental models C57BL/6NCrSlc (M. musculus) Japan SLC B6D2F1/Slc (M. musculus) Japan SLC (C57BL/6NCrSlc ♀ × DBA/2CrSlc ♂) F1 Tg(Spo11-cre)1Rsw (M. musculus) The Jackson Laboratory (Lyndaker et al, 2013) 032646 Tg(Gdf9-icre)5092Coo (M. musculus) The Jackson Laboratory (Lan et al, 2004) 011062 Tg(Zp3-cre)3Knw(M. musculus) The Jackson Laboratory (de Vries et al, 2000) 003651 Kif11 flox (M. musculus) This study Kif11flox/flox Zp3-Cre (M. musculus) This study Kif11flox/flox Gdf9-Cre (M. musculus) This study Recombinant DNA pGEMHE_EGFP-Map4 Schuh and Ellenberg 2007 pGEMHE_H2B-mCherry Kitajima et al, 2011 pGEMHE_mNeonGreenCep192 Kyogoku and Kitajima 2017 (originally Clift and Schuh 2015) pGEMHE_mCherry Asai et al, 2024 pGEMHE_Kif11-mCherry This study Reagent/resource Reference or source Identifier or catalog number pGEMHE_Kif11ΔmotormCherry This study pGEMHE_H2B-SNAP Takenouchi et al, 2024 Antibodies human anti-centromere protein antibody Antibodies Incorporated 15-234 rabbit anti-Kif11 Sigma HPA010568 rat monoclonal anti-alpha tubulin Bio-Rad MCA77G Alexa Fluor 488 goat antirabbit IgG (H+ L) Thermo Fisher A11034 Alexa Fluor 488 goat antirat IgG (H+ L) Thermo Fisher A11006 Alexa Fluor 555 goat antihuman IgG (H+ L) Thermo Fisher A21433 Oligonucleotides and other sequence-based reagents custom ssODN This study; Fasmac Figure EV1 crRNA Fasmac GE-001 tracrRNA Fasmac GE-002 Chemicals, enzymes and other reagents Equine chorionic gonadotropin ASKA Pharmaceutical G4877-2000IU CARD HyperOva KYUDO F-021 mMESSAGE mMACHINE T7 kit invitrogen AM1344 3-isobutyl-1-methylxanthine Sigma-Aldrich 15879 monastrol Sigma-Aldrich M815 EcoRV New England Biolabs R0195S SNAP-Cell 647-SiR New England Biolabs S9102S Hoechst 33342 Invitrogen H3570 SMART-Seq v4 Ultra Low Input RNA Kit for Sequencing Clontech 634891 Nextera XT DNA Library Preparation Kit Illumina FC-131-1096 8 EMBO reports © The Author(s) D ow nloaded from https://w w w .em bopress.org on Septem ber 7, 2025 from IP 2405:4803:dadf:58d0:bc82:365e:71c7:1d84. .. Reagent/resource Reference or source Identifier or catalog number Nextera XT Index Kit Illumina FC-131-1001 SPRISelect kit Beckman Coulter B23318 Software Fiji https://fiji.sc/ Imaris Oxford Instruments base R (v4.3.0) R Foundation for Statistical Computing fastp Chen et al, 2018 HiSat2 v2.2.1 Kim et al, 2019 SAMtools Danecek et al, 2021 featureCounts v2.0.3 Liao et al, 2014 DESeq2 Love et al, 2014 Other Illumina HiseqX Illumina LSM780, 880 confocal microscope Zeiss

    DNA Library Preparation:

    Article Title: Kif11-haploinsufficient oocytes reveal spatially differential requirements for chromosome biorientation.
    Article Snippet: .. Reagents and tools table Reagent/resource Reference or source Identifier or catalog number Experimental models C57BL/6NCrSlc (M. musculus) Japan SLC B6D2F1/Slc (M. musculus) Japan SLC (C57BL/6NCrSlc ♀ × DBA/2CrSlc ♂) F1 Tg(Spo11-cre)1Rsw (M. musculus) The Jackson Laboratory (Lyndaker et al, 2013) 032646 Tg(Gdf9-icre)5092Coo (M. musculus) The Jackson Laboratory (Lan et al, 2004) 011062 Tg(Zp3-cre)3Knw(M. musculus) The Jackson Laboratory (de Vries et al, 2000) 003651 Kif11 flox (M. musculus) This study Kif11flox/flox Zp3-Cre (M. musculus) This study Kif11flox/flox Gdf9-Cre (M. musculus) This study Recombinant DNA pGEMHE_EGFP-Map4 Schuh and Ellenberg 2007 pGEMHE_H2B-mCherry Kitajima et al, 2011 pGEMHE_mNeonGreenCep192 Kyogoku and Kitajima 2017 (originally Clift and Schuh 2015) pGEMHE_mCherry Asai et al, 2024 pGEMHE_Kif11-mCherry This study Reagent/resource Reference or source Identifier or catalog number pGEMHE_Kif11ΔmotormCherry This study pGEMHE_H2B-SNAP Takenouchi et al, 2024 Antibodies human anti-centromere protein antibody Antibodies Incorporated 15-234 rabbit anti-Kif11 Sigma HPA010568 rat monoclonal anti-alpha tubulin Bio-Rad MCA77G Alexa Fluor 488 goat antirabbit IgG (H+ L) Thermo Fisher A11034 Alexa Fluor 488 goat antirat IgG (H+ L) Thermo Fisher A11006 Alexa Fluor 555 goat antihuman IgG (H+ L) Thermo Fisher A21433 Oligonucleotides and other sequence-based reagents custom ssODN This study; Fasmac Figure EV1 crRNA Fasmac GE-001 tracrRNA Fasmac GE-002 Chemicals, enzymes and other reagents Equine chorionic gonadotropin ASKA Pharmaceutical G4877-2000IU CARD HyperOva KYUDO F-021 mMESSAGE mMACHINE T7 kit invitrogen AM1344 3-isobutyl-1-methylxanthine Sigma-Aldrich 15879 monastrol Sigma-Aldrich M815 EcoRV New England Biolabs R0195S SNAP-Cell 647-SiR New England Biolabs S9102S Hoechst 33342 Invitrogen H3570 SMART-Seq v4 Ultra Low Input RNA Kit for Sequencing Clontech 634891 Nextera XT DNA Library Preparation Kit Illumina FC-131-1096 8 EMBO reports © The Author(s) D ow nloaded from https://w w w .em bopress.org on Septem ber 7, 2025 from IP 2405:4803:dadf:58d0:bc82:365e:71c7:1d84. .. Reagent/resource Reference or source Identifier or catalog number Nextera XT Index Kit Illumina FC-131-1001 SPRISelect kit Beckman Coulter B23318 Software Fiji https://fiji.sc/ Imaris Oxford Instruments base R (v4.3.0) R Foundation for Statistical Computing fastp Chen et al, 2018 HiSat2 v2.2.1 Kim et al, 2019 SAMtools Danecek et al, 2021 featureCounts v2.0.3 Liao et al, 2014 DESeq2 Love et al, 2014 Other Illumina HiseqX Illumina LSM780, 880 confocal microscope Zeiss

    Staining:

    Article Title: Real-World Evidence on Outcomes and Safety of Ropeginterferon Alfa-2b in Patients With Myeloproliferative Neoplasms: A Retrospective Cohort Study.
    Article Snippet: This retrospective cohort study evaluated ropeginterferon alfa-2b in 64 patients with Philadelphia chromosome–negative myeloproliferative neoplasms.. Ropeginterferon demonstrated hematologic and molecular responses across subtypes, with significant reductions in JAK2 variant allele frequency.. However, efficacy was limited in myelofibrosis, particularly in patients harboring high-molecular-risk mutations.

    Polymerase Chain Reaction:

    Article Title: Real-World Evidence on Outcomes and Safety of Ropeginterferon Alfa-2b in Patients With Myeloproliferative Neoplasms: A Retrospective Cohort Study.
    Article Snippet: This retrospective cohort study evaluated ropeginterferon alfa-2b in 64 patients with Philadelphia chromosome–negative myeloproliferative neoplasms.. Ropeginterferon demonstrated hematologic and molecular responses across subtypes, with significant reductions in JAK2 variant allele frequency.. However, efficacy was limited in myelofibrosis, particularly in patients harboring high-molecular-risk mutations.

    Next-Generation Sequencing:

    Article Title: Real-World Evidence on Outcomes and Safety of Ropeginterferon Alfa-2b in Patients With Myeloproliferative Neoplasms: A Retrospective Cohort Study.
    Article Snippet: This retrospective cohort study evaluated ropeginterferon alfa-2b in 64 patients with Philadelphia chromosome–negative myeloproliferative neoplasms.. Ropeginterferon demonstrated hematologic and molecular responses across subtypes, with significant reductions in JAK2 variant allele frequency.. However, efficacy was limited in myelofibrosis, particularly in patients harboring high-molecular-risk mutations.

    Article Title: Liver single-nucleus multiome profiling reveals cell-type mechanisms for cardiometabolic traits
    Article Snippet: We purified sequencing libraries using SPRIselect beads, visualized using the Bioanalyzer High Sensitivity DNA chip, and quantified via KAPA Library Quantification Kit for Illumina Platforms (Roche PN-KK4824). .. We separately pooled ATAC and RNA sequencing libraries, spiked with 1% PhiX sequencing control (Illumina), and sequenced on a NovaSeq 6000 S4 array at the UNC High Throughput Sequencing Facility in paired-end format to a total depth of ~8 billion read pairs passing quality filters. .. We used CellRanger-ARC Count v2 (10X Genomics) to align sequencing reads to the GRCh38–2020-A human reference genome, using the filtered GENCODE V32 33 GTF file for gene quantification.

    Variant Assay:

    Article Title: Real-World Evidence on Outcomes and Safety of Ropeginterferon Alfa-2b in Patients With Myeloproliferative Neoplasms: A Retrospective Cohort Study.
    Article Snippet: This retrospective cohort study evaluated ropeginterferon alfa-2b in 64 patients with Philadelphia chromosome–negative myeloproliferative neoplasms.. Ropeginterferon demonstrated hematologic and molecular responses across subtypes, with significant reductions in JAK2 variant allele frequency.. However, efficacy was limited in myelofibrosis, particularly in patients harboring high-molecular-risk mutations.

    Modification:

    Article Title: Real-World Evidence on Outcomes and Safety of Ropeginterferon Alfa-2b in Patients With Myeloproliferative Neoplasms: A Retrospective Cohort Study.
    Article Snippet: This retrospective cohort study evaluated ropeginterferon alfa-2b in 64 patients with Philadelphia chromosome–negative myeloproliferative neoplasms.. Ropeginterferon demonstrated hematologic and molecular responses across subtypes, with significant reductions in JAK2 variant allele frequency.. However, efficacy was limited in myelofibrosis, particularly in patients harboring high-molecular-risk mutations.

    Mutagenesis:

    Article Title: Real-World Evidence on Outcomes and Safety of Ropeginterferon Alfa-2b in Patients With Myeloproliferative Neoplasms: A Retrospective Cohort Study.
    Article Snippet: This retrospective cohort study evaluated ropeginterferon alfa-2b in 64 patients with Philadelphia chromosome–negative myeloproliferative neoplasms.. Ropeginterferon demonstrated hematologic and molecular responses across subtypes, with significant reductions in JAK2 variant allele frequency.. However, efficacy was limited in myelofibrosis, particularly in patients harboring high-molecular-risk mutations.

    RNA Sequencing:

    Article Title: Liver single-nucleus multiome profiling reveals cell-type mechanisms for cardiometabolic traits
    Article Snippet: We purified sequencing libraries using SPRIselect beads, visualized using the Bioanalyzer High Sensitivity DNA chip, and quantified via KAPA Library Quantification Kit for Illumina Platforms (Roche PN-KK4824). .. We separately pooled ATAC and RNA sequencing libraries, spiked with 1% PhiX sequencing control (Illumina), and sequenced on a NovaSeq 6000 S4 array at the UNC High Throughput Sequencing Facility in paired-end format to a total depth of ~8 billion read pairs passing quality filters. .. We used CellRanger-ARC Count v2 (10X Genomics) to align sequencing reads to the GRCh38–2020-A human reference genome, using the filtered GENCODE V32 33 GTF file for gene quantification.



    Similar Products

    94
    R&D Systems human fc sequence
    Human Fc Sequence, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+fc+sequence/Recombinant+Human+CD155%2FPVR+Fc+Chimera+Protein%2C+CF/us12415854-917-10-15
    Average 94 stars, based on 1 article reviews
    human fc sequence - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    90
    Thermo Fisher synthetic gene coding fusion hil-7 sequence sequence human igg2-fc
    Synthetic Gene Coding Fusion Hil 7 Sequence Sequence Human Igg2 Fc, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+fc+sequence/pm35667841-50-16-20
    Average 90 stars, based on 1 article reviews
    synthetic gene coding fusion hil-7 sequence sequence human igg2-fc - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Antagen Pharmaceuticals a scfv-higg1 construct, where its scfv part utilizes anti-tnfα humira sequence to fuse with human igg1 fc,
    A Scfv Higg1 Construct, Where Its Scfv Part Utilizes Anti Tnfα Humira Sequence To Fuse With Human Igg1 Fc,, supplied by Antagen Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+fc+sequence/anti+mcd79b+pig+igg/pmc08315562-62-5-23
    Average 90 stars, based on 1 article reviews
    a scfv-higg1 construct, where its scfv part utilizes anti-tnfα humira sequence to fuse with human igg1 fc, - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Bioneer Corporation human igg1 fc coding sequence
    Human Igg1 Fc Coding Sequence, supplied by Bioneer Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+fc+sequence/humanized+igg1+ab+antibody/10__34172_slash_ps__2020__37-24-15-18
    Average 90 stars, based on 1 article reviews
    human igg1 fc coding sequence - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Twist Bioscience igg1 human fc sequence
    Animal <t>IgG</t> and serological competition. (A) IgG and serological competition schematic. Anti-His pAb captures SARS-CoV-2 spike protein. Immunized sera or IgG from small animals are used as competitors to block ACE2-IgHu receptor binding when premixed. ACE2-IgHu remaining is determined from an anti-human-HRP colorimetric readout. (B) IgGs present in a vaccinated BALB/c mouse block ACE2-IgHu binding with greater effect when the full-length SARS-CoV-2 S1-S2 spike protein is immobilized versus the S1 subunit by itself. (C) Area under the concentration-time curve (AUC) schematic displaying the larger area for uninhibited ACE2 binding versus the area from curves showing competition with ACE2. (D) AUC of IgGs purified from immunized rabbit sera (IgGr low dose, blue; IgGr high dose, red) versus naive IgGr or day 0 IgGr. (E) AUC of sera from immunized rabbits (low dose rabbit sera, blue; high dose rabbit sera, red) versus naive rabbit sera or day 0 rabbit sera. (F) AUC of sera from immunized guinea pigs at week 2 (dark blue) and individual animals (blue), naive sera (gray), and pooled day 0 sera from all animals (black). The pooled immunized curve displayed a comparable AUC to the average AUC from all individual immunized animals.
    Igg1 Human Fc Sequence, supplied by Twist Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+fc+sequence/ptwist+amp+high+copy/pmc07587116-45-3-19
    Average 90 stars, based on 1 article reviews
    igg1 human fc sequence - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    96
    Illumina Inc 4800 human genes
    Animal <t>IgG</t> and serological competition. (A) IgG and serological competition schematic. Anti-His pAb captures SARS-CoV-2 spike protein. Immunized sera or IgG from small animals are used as competitors to block ACE2-IgHu receptor binding when premixed. ACE2-IgHu remaining is determined from an anti-human-HRP colorimetric readout. (B) IgGs present in a vaccinated BALB/c mouse block ACE2-IgHu binding with greater effect when the full-length SARS-CoV-2 S1-S2 spike protein is immobilized versus the S1 subunit by itself. (C) Area under the concentration-time curve (AUC) schematic displaying the larger area for uninhibited ACE2 binding versus the area from curves showing competition with ACE2. (D) AUC of IgGs purified from immunized rabbit sera (IgGr low dose, blue; IgGr high dose, red) versus naive IgGr or day 0 IgGr. (E) AUC of sera from immunized rabbits (low dose rabbit sera, blue; high dose rabbit sera, red) versus naive rabbit sera or day 0 rabbit sera. (F) AUC of sera from immunized guinea pigs at week 2 (dark blue) and individual animals (blue), naive sera (gray), and pooled day 0 sera from all animals (black). The pooled immunized curve displayed a comparable AUC to the average AUC from all individual immunized animals.
    4800 Human Genes, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+fc+sequence/TruSight+One+Sequencing+Panel/pmc07322863-25-4-11
    Average 96 stars, based on 1 article reviews
    4800 human genes - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    97
    InvivoGen human fc sequence
    Animal <t>IgG</t> and serological competition. (A) IgG and serological competition schematic. Anti-His pAb captures SARS-CoV-2 spike protein. Immunized sera or IgG from small animals are used as competitors to block ACE2-IgHu receptor binding when premixed. ACE2-IgHu remaining is determined from an anti-human-HRP colorimetric readout. (B) IgGs present in a vaccinated BALB/c mouse block ACE2-IgHu binding with greater effect when the full-length SARS-CoV-2 S1-S2 spike protein is immobilized versus the S1 subunit by itself. (C) Area under the concentration-time curve (AUC) schematic displaying the larger area for uninhibited ACE2 binding versus the area from curves showing competition with ACE2. (D) AUC of IgGs purified from immunized rabbit sera (IgGr low dose, blue; IgGr high dose, red) versus naive IgGr or day 0 IgGr. (E) AUC of sera from immunized rabbits (low dose rabbit sera, blue; high dose rabbit sera, red) versus naive rabbit sera or day 0 rabbit sera. (F) AUC of sera from immunized guinea pigs at week 2 (dark blue) and individual animals (blue), naive sera (gray), and pooled day 0 sera from all animals (black). The pooled immunized curve displayed a comparable AUC to the average AUC from all individual immunized animals.
    Human Fc Sequence, supplied by InvivoGen, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+fc+sequence/pFUSE-hIgG2-Fc2/us10562980-2235-10-21
    Average 97 stars, based on 1 article reviews
    human fc sequence - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    90
    GenScript corporation codon-optimized sequences for human gdf11 and human gdf11pro-fc
    Animal <t>IgG</t> and serological competition. (A) IgG and serological competition schematic. Anti-His pAb captures SARS-CoV-2 spike protein. Immunized sera or IgG from small animals are used as competitors to block ACE2-IgHu receptor binding when premixed. ACE2-IgHu remaining is determined from an anti-human-HRP colorimetric readout. (B) IgGs present in a vaccinated BALB/c mouse block ACE2-IgHu binding with greater effect when the full-length SARS-CoV-2 S1-S2 spike protein is immobilized versus the S1 subunit by itself. (C) Area under the concentration-time curve (AUC) schematic displaying the larger area for uninhibited ACE2 binding versus the area from curves showing competition with ACE2. (D) AUC of IgGs purified from immunized rabbit sera (IgGr low dose, blue; IgGr high dose, red) versus naive IgGr or day 0 IgGr. (E) AUC of sera from immunized rabbits (low dose rabbit sera, blue; high dose rabbit sera, red) versus naive rabbit sera or day 0 rabbit sera. (F) AUC of sera from immunized guinea pigs at week 2 (dark blue) and individual animals (blue), naive sera (gray), and pooled day 0 sera from all animals (black). The pooled immunized curve displayed a comparable AUC to the average AUC from all individual immunized animals.
    Codon Optimized Sequences For Human Gdf11 And Human Gdf11pro Fc, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+fc+sequence/codon+optimized+sequences+for+human+gdf11+and+human+gdf11pro+fc/pmc06537384-52-8-12
    Average 90 stars, based on 1 article reviews
    codon-optimized sequences for human gdf11 and human gdf11pro-fc - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    96
    Illumina Inc human disease
    Animal <t>IgG</t> and serological competition. (A) IgG and serological competition schematic. Anti-His pAb captures SARS-CoV-2 spike protein. Immunized sera or IgG from small animals are used as competitors to block ACE2-IgHu receptor binding when premixed. ACE2-IgHu remaining is determined from an anti-human-HRP colorimetric readout. (B) IgGs present in a vaccinated BALB/c mouse block ACE2-IgHu binding with greater effect when the full-length SARS-CoV-2 S1-S2 spike protein is immobilized versus the S1 subunit by itself. (C) Area under the concentration-time curve (AUC) schematic displaying the larger area for uninhibited ACE2 binding versus the area from curves showing competition with ACE2. (D) AUC of IgGs purified from immunized rabbit sera (IgGr low dose, blue; IgGr high dose, red) versus naive IgGr or day 0 IgGr. (E) AUC of sera from immunized rabbits (low dose rabbit sera, blue; high dose rabbit sera, red) versus naive rabbit sera or day 0 rabbit sera. (F) AUC of sera from immunized guinea pigs at week 2 (dark blue) and individual animals (blue), naive sera (gray), and pooled day 0 sera from all animals (black). The pooled immunized curve displayed a comparable AUC to the average AUC from all individual immunized animals.
    Human Disease, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+fc+sequence/TruSight+One+Sequencing+Panel/10__3233_slash_jnd___189001-6817-10-17
    Average 96 stars, based on 1 article reviews
    human disease - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    Image Search Results


    Animal IgG and serological competition. (A) IgG and serological competition schematic. Anti-His pAb captures SARS-CoV-2 spike protein. Immunized sera or IgG from small animals are used as competitors to block ACE2-IgHu receptor binding when premixed. ACE2-IgHu remaining is determined from an anti-human-HRP colorimetric readout. (B) IgGs present in a vaccinated BALB/c mouse block ACE2-IgHu binding with greater effect when the full-length SARS-CoV-2 S1-S2 spike protein is immobilized versus the S1 subunit by itself. (C) Area under the concentration-time curve (AUC) schematic displaying the larger area for uninhibited ACE2 binding versus the area from curves showing competition with ACE2. (D) AUC of IgGs purified from immunized rabbit sera (IgGr low dose, blue; IgGr high dose, red) versus naive IgGr or day 0 IgGr. (E) AUC of sera from immunized rabbits (low dose rabbit sera, blue; high dose rabbit sera, red) versus naive rabbit sera or day 0 rabbit sera. (F) AUC of sera from immunized guinea pigs at week 2 (dark blue) and individual animals (blue), naive sera (gray), and pooled day 0 sera from all animals (black). The pooled immunized curve displayed a comparable AUC to the average AUC from all individual immunized animals.

    Journal: Journal of Clinical Microbiology

    Article Title: SARS-CoV-2 Assays To Detect Functional Antibody Responses That Block ACE2 Recognition in Vaccinated Animals and Infected Patients

    doi: 10.1128/JCM.01533-20

    Figure Lengend Snippet: Animal IgG and serological competition. (A) IgG and serological competition schematic. Anti-His pAb captures SARS-CoV-2 spike protein. Immunized sera or IgG from small animals are used as competitors to block ACE2-IgHu receptor binding when premixed. ACE2-IgHu remaining is determined from an anti-human-HRP colorimetric readout. (B) IgGs present in a vaccinated BALB/c mouse block ACE2-IgHu binding with greater effect when the full-length SARS-CoV-2 S1-S2 spike protein is immobilized versus the S1 subunit by itself. (C) Area under the concentration-time curve (AUC) schematic displaying the larger area for uninhibited ACE2 binding versus the area from curves showing competition with ACE2. (D) AUC of IgGs purified from immunized rabbit sera (IgGr low dose, blue; IgGr high dose, red) versus naive IgGr or day 0 IgGr. (E) AUC of sera from immunized rabbits (low dose rabbit sera, blue; high dose rabbit sera, red) versus naive rabbit sera or day 0 rabbit sera. (F) AUC of sera from immunized guinea pigs at week 2 (dark blue) and individual animals (blue), naive sera (gray), and pooled day 0 sera from all animals (black). The pooled immunized curve displayed a comparable AUC to the average AUC from all individual immunized animals.

    Article Snippet: DNA encoding the IgG1 human Fc sequence was added to the C terminus of the huACE2 and cloned by Twist Bioscience into a modified mammalian pVax-1 expression plasmid to generate the recombinant plasmid ACE2-IgHu.

    Techniques: Blocking Assay, Binding Assay, Concentration Assay, Purification